SciLifeLab Roadmap 2020-2030
A document outlining SciLifeLab’s goals ahead
The Roadmap 2020-2030 describes what SciLifeLab want to achieve in the coming decade and why. It focuses on what we can accomplish together with all of our stakeholders, maximizing the capacity of the Swedish life science ecosystem as a whole, by increasing quality and international competitiveness of research through continued efforts on technology-driven infrastructure, as well as new focus on data-driven life science. Detailed plans as how to achieve the objectives will be further defined in the daily operations of our infrastructure and research community together with key collaborators.
SciLifeLab 10-year strategy was developed by the SciLifeLab Management group with input from the International Advisory Board, members of the SciLifeLab Board, Data Centre, Operations Office, host university leadership and SciLifeLab Committees, the National SciLifeLab Committee, and in dialogue with SciLifeLab infrastructure platforms and the overall SciLifeLab community.
We are also grateful for valuable contribution and input from the following organizations in preparation of this roadmap: Apotekarsocieteten, AstraZeneca, Bayer, Beactica AB, Chalmers tekniska högskola, European Spallation Source (ESS), Genomic Medicine Sweden, Göteborgs universitet, Janssen, Karolinska Institutet, Karolinska Institutet Innovations AB, Kungliga Tekniska Högskolan (KTH), Linköpings universitet, Läkemedelsindustriföreningen (LIF), Lunds Universitet, MAX-IV, Naturhistoriska Riksmuseet, Naturvårdsverket, NBIS, Pfizer, Region Skåne, Region Stockholm, Region Uppsala, Region Västerbotten, Region Örebro län, Region Östergötland, RISE, Sveriges Lantbruksuniversitet (SLU), Stockholms universitet, STUNS/Uppsala Bio, SwedenBio, SWElife, Umeå universitet, Uppsala universitet, Uppsala Universitet Innovation, Vinnova, Vetenskapsrådet, Västra Götalandsregionen.
If you have questions regarding this Roadmap, please contact: email@example.com